You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 1, JANUARY 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acetazolamide in Phenobarbital Intoxication

WILLIAM N. KELLEY, MD; ARTHUR P. RICHARDSON, JR., MD; MORTON F. MASON, PhD; FLOYD C. RECTOR, JR., MD

Arch Intern Med. 1966;117(1):64-69.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE BARBITURATES can be divided into two groups on the basis of their metabolism. One group is metabolized primarily by the liver. The short-acting drugs, in general, fit into this group. The second group comprises those barbiturates in which elimination of the active agent is primarily by renal excretion with inactivation by the liver being of less significance. Phenobarbital, allobarbital, aprobarbital, butallylonal, phenylmethybarbituric acid, and barbital are the agents eliminated primarily by the kidney.1 In this country phenobarbital is the member of this group which is most commonly used clinically.

Phenobarbital is excreted into the urine by means of glomerular filtration and tubular reabsorption without tubular secretion. Waddell and Butler 2 found that the excretion of phenobarbital is influenced by both urine pH and urine flow. On the basis of this finding they suggested that only the unionized, lipid-soluble form of the drug is reabsorbed, presumably by passive nonionic . . . [Full Text PDF of this Article]


Author Affiliations

DALLAS

From the Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas.


Footnotes

Received for publication June 2, 1965; accepted Sept 20.

Reprint requests to 5323 Harry Hines Blvd, Dallas, Tex 75235 (Dr. F. C. Rector, Jr.).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.